Brief: China is no longer strategic for Diasorin, CEO says
14/03/2025 17:45
March 14 (Reuters) - DiaSorin CEO Carlo Rosa tells analysts: CHINA IS NO LONGER STRATEGIC FOR THE COMPANY SEES 2025 DOUBLE-DIGIT REVENUE GROWTH IN US AND HIGH SINGLE-DIGIT IN EUROPE CURRENT GUIDANCE INCLUDES NEW TARIFFS IN U.S., CHINA, CANADA, MEXICO Further company coverage: DIAS.MI ((gianluca.semeraro@tr.com; +39 06 80 307 741;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21